Fig. 3From: Integrated plasma metabolomics and lipidomics profiling highlights distinctive signature of hepatocellular carcinoma in HCV patientsA–D Distribution in HCC, HCV and MC patients of short (A), medium (B) and long-chain (C) acylcarnitine (CAR) and D Ile-Pro, ADMA and MG, where *p-value < 0.05 and **p-value < 0.01Back to article page